Principal Biostatistician visa sponsorship salary
Across 32 certified work-visa filings, the median wage for Principal Biostatistician is $142,771. The middle half of filings fall between $124,831 and $144,925, and the top decile begins at $166,756. Classified under SOC 15-2041.01 (Biostatisticians).
Median
$142,771
25th pct
$124,831
75th pct
$144,925
90th pct
$166,756
Filings
32
$94,689$175,067
Who pays what for Principal Biostatistician
Ranked by number of certified filings
| Employer | Filings | 25th | Median | 75th |
|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $142,771 | $142,771 | $142,771 |
| Vertex Pharmaceuticals Incorporated | 5 | $144,925 | $144,925 | $144,925 |
| Sandoz Inc. | 2 | $168,352 | $169,754 | $171,155 |
| Edwards Lifesciences LLC | 2 | $118,664 | $118,664 | $118,664 |
| Incyte Corporation | 2 | $111,294 | $115,863 | $120,431 |
| Syneos Health US, Inc. | 2 | $99,263 | $111,873 | $124,483 |
Individual filings
Most recent certified determinations
| Employer | Location | Wage | Level | Decided |
|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | East Hanover, NJ | $144,373 | III | Sep 23, 2025 |
| Novartis Pharmaceuticals Corporation | East Hanover, NJ | $144,373 | III | Sep 15, 2025 |
| Novartis Pharmaceuticals Corporation | East Hanover, NJ | $112,965 | II | Sep 2, 2025 |
| Vertex Pharmaceuticals Incorporated | Boston, MA | $144,925 | IV | Aug 25, 2025 |
| Uswm Ct, LLC | Louisville, KY | $177,679 | IV | Aug 21, 2025 |
| Sandoz Inc. | Princeton, NJ | $166,951 | III | Aug 14, 2025 |
| Vertex Pharmaceuticals Incorporated | Boston, MA | $144,925 | IV | Aug 8, 2025 |
| Vertex Pharmaceuticals Incorporated | Boston, MA | $144,925 | IV | Aug 8, 2025 |
| Vertex Pharmaceuticals Incorporated | Boston, MA | $144,925 | IV | Aug 8, 2025 |
| Neurocrine Biosciences, Inc. | San Diego, CA | $141,856 | IV | Jul 31, 2025 |
| Syneos Health US, Inc. | West Chester, PA | $137,093 | IV | Jul 31, 2025 |
| Syneos Health US, Inc. | West Bloomfield, MI | $86,653 | II | Jul 1, 2025 |
| Incyte Corporation | Wilmington, DE | $106,725 | III | May 28, 2025 |
| Sandoz Inc. | Princeton, NJ | $172,557 | II | May 27, 2025 |
| ClinChoice Inc. | Horsham, PA | $163,582 | II | May 22, 2025 |
| Parexel International LLC | Newton, MA | $162,000 | II | May 21, 2025 |
| Fortrea Inc. f/k/a LabCorp Drug Development Inc. | Durham, NC | $165,000 | III | May 21, 2025 |
| Incyte Corporation | Wilmington, DE | $125,000 | III | May 2, 2025 |
| Novartis Institutes for BioMedical Research, Inc. | Cambridge, MA | $106,600 | III | Apr 9, 2025 |
| Biogen Inc. | Eagle Mountain, UT | $107,000 | III | Apr 2, 2025 |
| Novartis Pharmaceuticals Corporation | Cambridge, MA | $124,322 | IV | Apr 1, 2025 |
| Novartis Pharmaceuticals Corporation | East Hanover, NJ | $142,771 | III | Mar 31, 2025 |
| Novartis Pharmaceuticals Corporation | East Hanover, NJ | $142,771 | III | Mar 31, 2025 |
| Novartis Pharmaceuticals Corporation | East Hanover, NJ | $142,771 | III | Mar 31, 2025 |
| Novartis Pharmaceuticals Corporation | East Hanover, NJ | $142,771 | III | Mar 31, 2025 |
Prevailing wage levels I through IV reflect the experience and responsibility the employer attested to, not seniority titles. A level I filing is an entry-level determination; level IV is fully competent and independent. Comparing across levels explains much of the spread between the 25th and 90th percentile above.